Page 8 of 32
Novo’s CagriSema beat a low dose of Lilly’s tirzepatide on 21 September, but investors sold on 2030 ambitions that pitch the drugmaker as an ordinary-growth pharma
Dangote’s next chapter rests on three daughters and a 2030 target
Deutsche Bank, Société Générale, Santander and four members of a euro stablecoin consortium joined the ECB’s central bank settlement rail on its first day
The Nigerian IPO comes first, but Chairman Aliko Dangote is looking towards something bigger.
Up to $1 billion in passive capital is now eyeing NGX stocks
Bamboo and Cowrywise are waiving every fee on the Dangote IPO because the customer is worth more than the transaction.
Otedola spent decades building wealth through oil and power, but a banking giant now accounts for most of his billionaire fortune.
Medtronic’s robotic platform now has its vessel-sealing tool in the US, but the procedures it can actually perform there haven’t changed yet.
Buffett completed a 61-year transition that puts the trillion-dollar conglomerate fully into the hands of its next generation.
Aradel Holdings captured nearly a fifth of all trade value on the Nigerian Exchange as oil stocks powered a fifth consecutive day of gains.
AI stocks rallied after the Fed hiked rates, but not everyone is buying the bounce.
J&J sold its $400 million Laminar program, narrowing competition for Boston Scientific and Abbott in LAA closure.
Newsletter
One email every Sunday. The week’s most useful guides, market-moving stories, and practical tools — chosen by our editors.
